SCHEMBL19212145

SCHEMBL19212145

O=C(NCCc1cc(F)c(N2CCN(C(=O)O)CC2)cc1F)OCc1ccccc1

nearest known ligand 0.45

Predicted protein targets (top 18)

geneUniProtsupporting neighboursconfidence
GRM5 P41594 2/20 0.45
L3MBTL1 Q9Y468 2/20 0.45
SMN1; SMN2 Q16637 3/20 0.44
LMNA P02545 3/20 0.44
ALDH1A1 P00352 2/20 0.43
MAPT P10636 2/20 0.43
IDO1 P14902 1/20 0.42
HTT P42858 1/20 0.42
GAA P10253 2/20 0.41
KMT2A Q03164 2/20 0.41
PREP P48147 2/20 0.41
USP28 Q96RU2 2/20 0.41
USP25 Q9UHP3 2/20 0.41
HPGD P15428 1/20 0.40
DPP4 P27487 1/20 0.40
MEN1 O00255 1/20 0.40
KCNA5 P22460 1/20 0.39
KAT2B Q92831 1/20 0.39

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL28698477 0.89 BACE1 (0.47) GRM5L3MBTL1LMNAALDH1A1MAPT
SCHEMBL28673972 0.89 LMNA (0.46) L3MBTL1SMN1; SMN2LMNAALDH1A1MAPT
SCHEMBL19212115 0.87 GRM5 (0.51) GRM5L3MBTL1SMN1; SMN2LMNAALDH1A1
SCHEMBL19211018 0.83 LMNA (0.41) L3MBTL1SMN1; SMN2LMNAALDH1A1IDO1
SCHEMBL28931815 0.82 LMNA (0.41) L3MBTL1SMN1; SMN2LMNAIDO1HTT
SCHEMBL19212126 0.80 LMNA (0.40) L3MBTL1SMN1; SMN2LMNAMAPTIDO1
SCHEMBL19210903 0.80 GRM5 (0.50) GRM5L3MBTL1SMN1; SMN2LMNAALDH1A1
SCHEMBL19212112 0.79 LMNA (0.44) GRM5L3MBTL1SMN1; SMN2LMNAMAPT
SCHEMBL28697404 0.78 ABCB1 (0.43) L3MBTL1MAPT
SCHEMBL21457808 0.78 ABCB1 (0.42) MAPTIDO1KMT2AUSP28USP25

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-3414252-A1 THIENOPYRIDINE CARBOXAMIDES AS UBIQUITIN-SPECIFIC PROTEASE INHIBITORS Forma Therapeutics, Inc. (US) 2018-12-19 EP disclosed
WO-2017139778-A1 THIENOPYRIDINE CARBOXAMIDES AS UBIQUITIN-SPECIFIC PROTEASE INHIBITORS FORMA THERAPEUTICS, INC. (US) 2017-08-17 WO disclosed